MwanzoDMYD-B • STO
add
Diamyd Medical AB
Bei iliyotangulia
kr 17.18
Bei za siku
kr 16.86 - kr 17.40
Bei za mwaka
kr 8.10 - kr 25.00
Thamani ya kampuni katika soko
1.76B SEK
Wastani wa hisa zilizouzwa
elfu 251.02
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
STO
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (SEK) | Nov 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 25.00 | -26.47% |
Matumizi ya uendeshaji wa biashara | 41.86M | 40.27% |
Mapato halisi | -36.16M | -10.31% |
Kiwango cha faida halisi | elfu -144.65 | -50.02% |
Mapato kwa kila hisa | — | — |
EBITDA | -41.40M | -39.63% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (SEK) | Nov 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 152.88M | -13.49% |
Jumla ya mali | 222.89M | -15.45% |
Jumla ya dhima | 66.78M | 25.66% |
Jumla ya hisa | 156.11M | — |
hisa zilizosalia | 104.09M | — |
Uwiano wa bei na thamani | 11.45 | — |
Faida inayotokana na mali | -48.78% | — |
Faida inayotokana mtaji | -71.05% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (SEK) | Nov 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -36.16M | -10.31% |
Pesa kutokana na shughuli | -41.82M | -50.37% |
Pesa kutokana na uwekezaji | 24.06M | 820.26% |
Pesa kutokana na ufadhili | 59.07M | -27.87% |
Mabadiliko halisi ya pesa taslimu | 40.12M | -18.43% |
Mtiririko huru wa pesa | -31.11M | -43.94% |
Kuhusu
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1984
Tovuti
Wafanyakazi
29
